Eastman Chemical rated Impartial in initiation report from Mizuho (NYSE:EMN)
[ad_1]
Eastman Chemical (NYSE:EMN) was rated Impartial in an initiation of protection report by analysts at Mizuho Securities. They stated the corporate faces challenges with declining demand for petrochemicals.
“We stay cautious on the worldwide financial outlook and imagine there could possibly be additional draw back to estimates, holding us on the sidelines,” Kieran de Drun, analyst at Mizuho, stated within the report dated Oct. 10.
It set a worth goal of $91 a share based mostly on a a number of of seven occasions its estimate for Eastman’s 2024 EBITDA, discounted to the current.
Mizuho additionally initiated protection of chemical and specialty-materials maker Celanese (CE) with a Impartial score.
Eastman this 12 months has declined 40%, in contrast with a 25% decline for the S&P 500 Inventory Index (SP500).
Looking for Alpha columnist Mike Zaccardi has a Purchase score on Eastman Chemical (EMN) due to its valuation. Contributor PatientValueInvestor additionally charges Eastman (EMN) as a Purchase on its steadiness sheet and dividend protection.
Mizuho’s estimates for chemical makers, Oct. 10 | ||||
P/E | ||||
2020 | 2021E | 2022E | 2023E | |
Firm (Ticker) | ||||
Celanese (CE) | 11.8x | 5x | 5.1x | 6x |
Eastman Chemical (EMN) | 11.8x | 8.2x | 8x | 7.5x |
Westlake (WLK) | 34.7x | 5.7x | 4.3x | 6.4x |
Dow Inc (DOW) | 26.8x | 4.9x | 6.3x | 7.8x |
LyondellBasell (LYB) | 14x | 4.3x | 5.1x | 5.8x |
BASF (OTCQX:BASFY) | 10.8x | 5x | 6.2x | 8x |
Common | 19.6x | 5.6x | 6x | 7.1x |
Source link